← Return to Clinical Trials Feed
📅 TRIAL CALENDAR

Clinical Trials Calendar 2026

50 clinical trials with confirmed start dates — sorted by most recent. Track recruiting studies across all phases, conditions, and sponsors worldwide.

TRIALS: 50 // RECRUITING: 50 // SOURCE: CLINICALTRIALS.GOV // UPDATED: DAILY

July 2026 (3 trials)

NCT07701616 N/A
Recruiting
Digital Mindfulness-Based Therapy for Obsessive-Compulsive Disorder
Condition
Obsessive-Compulsive Disorder
Start Date
Jul 15, 2026
Location
China
Sponsor
Central South University
View Trial →
NCT07048314 Phase 1, Phase 2
Recruiting
Stem Cells for Erectile Dysfunction Post RALP
Condition
Erectile Dysfunction
Start Date
Jul 7, 2026
Location
United States
Sponsor
The Methodist Hospital Researc
View Trial →
NCT07640516 N/A
Recruiting
The Analgesic Efficacy of Dexmedetomidine Versus Fentanyl as an Adjuvant to Bupi...
Condition
Analgesia Assessment
Start Date
Jul 1, 2026
Location
Egypt
Sponsor
Kasr El Aini Hospital
View Trial →

March 2026 (1 trials)

NCT07027306 N/A
Recruiting
The Osteoporotic Fracture Classification-based Scoring System for Treatment Deci...
Condition
Osteoporotic Fractures
Start Date
Mar 19, 2026
Location
United States, Argentina, Brazil
Sponsor
AO Foundation, AO Spine
View Trial →

December 2025 (2 trials)

NCT07258121 Phase 1, Phase 2
Recruiting
Study of ZGGS34 in Participants With Advanced Solid Tumors
Condition
Solid Tumor
Start Date
Dec 31, 2025
Location
China
Sponsor
Suzhou Zelgen Biopharmaceutica
View Trial →
NCT07485114 N/A
Recruiting
Association Between Galectin-3 Levels and Outcomes in Patients With Renal Cell C...
Condition
Renal Cell Carcinoma (Kidney Cancer)
Start Date
Dec 3, 2025
Location
Israel
Sponsor
Daniel Keizman
View Trial →

November 2025 (1 trials)

NCT07175493 Phase 1, Phase 2
Recruiting
A Study of CM336 in Patients With Relapsed or Refractory Autoimmune Cytopenia
Condition
Autoimmune Cytopenia
Start Date
Nov 18, 2025
Location
China
Sponsor
Keymed Biosciences Co.Ltd
View Trial →

October 2025 (1 trials)

NCT06626516 Phase 1, Phase 2
Recruiting
Tebentafusp-tebn With LDT in Metastatic UM
Condition
Metastatic Uveal Melanoma
Start Date
Oct 15, 2025
Location
United States
Sponsor
Thomas Jefferson University
View Trial →

September 2025 (1 trials)

NCT07149246 N/A
Recruiting
The Effect of a 6-month Dietitian-tailored Nutrition Intervention to Patients Wi...
Condition
ICU Patients
Start Date
Sep 1, 2025
Location
Norway
Sponsor
University Hospital of North N
View Trial →

August 2025 (3 trials)

NCT06982521 Phase 3
Recruiting
Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatme...
Condition
PIK3CA Mutation
Start Date
Aug 26, 2025
Location
United States, Argentina, Australia
Sponsor
Relay Therapeutics, Inc.
View Trial →
NCT06627504 N/A
Recruiting
Type 1 Diabetes REst for Metabolic Health
Condition
Type 1 Diabetes (T1D)
Start Date
Aug 12, 2025
Location
United States
Sponsor
University of Colorado, Denver
View Trial →
NCT07075016 Phase 3
Recruiting
Ivosidenib and Azacitidine With or Without Venetoclax in Adult Patients With New...
Condition
Acute Myeloid Leukemia
Start Date
Aug 5, 2025
Location
Austria, Belgium, Denmark
Sponsor
Stichting Hemato-Oncologie voo
View Trial →

June 2025 (2 trials)

NCT06860516 N/A
Recruiting
HLA Demographics Study in Adults With Type 1 Diabetes
Condition
Diabetes Mellitus, Type I
Start Date
Jun 6, 2025
Location
United States
Sponsor
GentiBio, Inc
View Trial →
NCT06962306 Phase 4
Recruiting
Optimizing Perioperative Analgesia to Lower Pain Following Cleft Palate Surgery
Condition
Cleft Palate
Start Date
Jun 4, 2025
Location
United States
Sponsor
Duke University
View Trial →

April 2025 (1 trials)

NCT06917963 N/A
Recruiting
Study of Treatment With Intensified Omeprazole Treatment to Prevent High Output ...
Condition
Stoma - Ileostomy
Start Date
Apr 10, 2025
Location
Poland
Sponsor
Medical University of Gdansk
View Trial →

March 2025 (1 trials)

NCT06915116 Phase 2
Recruiting
Acupuncture for People Experiencing Period Loss Due to Chemotherapy
Condition
Cancer
Start Date
Mar 31, 2025
Location
United States
Sponsor
Memorial Sloan Kettering Cance
View Trial →

February 2025 (1 trials)

NCT06975306 N/A
Recruiting
Radiographic Findings and Clinical Outcomes After Bone Grafting Patellar Defect ...
Condition
Bone Graft; Complications
Start Date
Feb 11, 2025
Location
United States
Sponsor
University of Arizona
View Trial →

November 2024 (2 trials)

NCT06041763 N/A
Recruiting
Bridge-Enhanced ACL Repair (BEAR) in Meniscus Repair
Condition
Meniscus Tear
Start Date
Nov 20, 2024
Location
United States
Sponsor
NYU Langone Health
View Trial →
NCT06857604 N/A
Recruiting
The Interplay Between Inborn Error of Immunity and Blood Disorders: Unravelling ...
Condition
Hematologic Diseases
Start Date
Nov 15, 2024
Location
Canada, France, Italy
Sponsor
Meyer Children's Hospital IRCC
View Trial →

October 2024 (2 trials)

NCT06630806 Phase 1
Recruiting
A Study to Investigate the Safety and Efficacy of SAR446523 Injected Subcutaneou...
Condition
Plasma Cell Myeloma Refractory
Start Date
Oct 30, 2024
Location
United States, Australia, Canada
Sponsor
Sanofi
View Trial →
NCT06551116 N/A
Recruiting
QuantifyHER: Quantitative Immunofluorescence and/or RT-qPCR for Measuring HER2 i...
Condition
HER2-positive Metastatic Breast Cancer
Start Date
Oct 10, 2024
Location
United States
Sponsor
Abramson Cancer Center at Penn
View Trial →

July 2024 (3 trials)

NCT06392906 Phase 3
Recruiting
Orbital Radiotherapy in Grave's Ophthalmopathy 1 Week vs 2 Weeks (OraGO-1 Trial)
Condition
Thyroid Associated Ophthalmopathy
Start Date
Jul 11, 2024
Location
Thailand
Sponsor
Janjira Petsuksiri
View Trial →
NCT07451106 N/A
Recruiting
Exploring Clinical Utility of Wearables for the Bladder in Pelvic Health Physica...
Condition
Postpartum Bladder Dysfunction
Start Date
Jul 11, 2024
Location
United States
Sponsor
University of California, San
View Trial →
NCT06569459 Phase 2
Recruiting
Trilaciclib Combined With Concurrent Chemoradiotherapy and Immunotherapy in the ...
Condition
Esophageal Cancer
Start Date
Jul 9, 2024
Location
China
Sponsor
The First Affiliated Hospital
View Trial →

June 2024 (3 trials)

NCT06459024 N/A
Recruiting
Master Framework For Relapse or Refractory Acute Myeloid Leukemia
Condition
Acute Myeloid Leukemia, in Relapse
Start Date
Jun 28, 2024
Location
Germany, Italy, Lithuania
Sponsor
Istituto Romagnolo per lo Stud
View Trial →
NCT06437509 Phase 2
Recruiting
A Study of BL-B01D1+PD-1 Monoclonal Antibody in Patients With Extensive-stage Sm...
Condition
Extensive-stage Small-cell Lung Cancer
Start Date
Jun 13, 2024
Location
China
Sponsor
Sichuan Baili Pharmaceutical C
View Trial →
NCT06282406 N/A
Recruiting
Pupil-Indexed Noninvasive Neuromodulation
Condition
Paresis
Start Date
Jun 3, 2024
Location
United States
Sponsor
VA Office of Research and Deve
View Trial →

April 2024 (1 trials)

NCT06362304 N/A
Recruiting
99mTc-CNDG SPECT/CT in Brain Tumors
Condition
Intracranial Tumor
Start Date
Apr 20, 2024
Location
China
Sponsor
Peking Union Medical College H
View Trial →

March 2024 (1 trials)

NCT06344416 N/A
Recruiting
Open Label, Controlled, Post Marketing, Registry Study of Ribociclib (Ribo) Trea...
Condition
Any Solid Oral Medication
Start Date
Mar 30, 2024
Location
United States
Sponsor
Dosentrx Ltd.
View Trial →

January 2024 (1 trials)

NCT05958563 N/A
Recruiting
Impact of Continuous Positive Airway Pressure on the Occurrence of Acute Exacerb...
Condition
Sleep Apnea
Start Date
Jan 9, 2024
Location
France
Sponsor
University Hospital, Angers
View Trial →

December 2023 (1 trials)

NCT06156306 N/A
Recruiting
CBT-I Versus CBT-I+ACT for Youths With Insomnia and Anxiety
Condition
Insomnia
Start Date
Dec 15, 2023
Location
Hong Kong
Sponsor
Chinese University of Hong Kon
View Trial →

November 2023 (2 trials)

NCT06091904 N/A
Recruiting
Effects of Sufentanil on the Intraoperative Hemodynamics
Condition
Intraoperative Hypotension
Start Date
Nov 24, 2023
Location
South Korea
Sponsor
Seoul National University Hosp
View Trial →
NCT06204406 N/A
Recruiting
Prognosis of Patients With Upper Tract Urothelial Carcinoma Receiving Kidney-spa...
Condition
Upper Tract Urothelial Carcinoma Receiving Kidney-sparing Therapy
Start Date
Nov 23, 2023
Location
China
Sponsor
RenJi Hospital
View Trial →

October 2023 (1 trials)

NCT05724004 N/A
Recruiting
Alectinib Followed by Concomitant Consolidation Radiation Therapy in Advanced NS...
Condition
Radiotherapy Side Effect
Start Date
Oct 5, 2023
Location
Sweden
Sponsor
Karolinska University Hospital
View Trial →

July 2023 (1 trials)

NCT05962216 N/A
Recruiting
Real-life Assessment of Brexpiprazole (Rexulti) in Schizophrenia and in Depressi...
Condition
Psychosis
Start Date
Jul 1, 2023
Location
Hong Kong
Sponsor
Dr. Albert Kar-Kin Chung
View Trial →

February 2023 (2 trials)

NCT05732116 N/A
Recruiting
PTSD of Surgeons or Anesthesiologists on Prognosis of Surgical Patients
Condition
Post Traumatic Stress Disorder
Start Date
Feb 21, 2023
Location
China
Sponsor
Xijing Hospital
View Trial →
NCT06513416 N/A
Recruiting
Gut Microbiota and Pulmonary Complications After Non Cardiac Elective Surgery in...
Condition
Gut Microbiota
Start Date
Feb 1, 2023
Location
China
Sponsor
Peking Union Medical College H
View Trial →

January 2023 (2 trials)

NCT05696704 N/A
Recruiting
Telehealth to Reduce Mental Health in Family Caregivers
Condition
Mental Health Issue
Start Date
Jan 30, 2023
Location
United States
Sponsor
Texas Tech University
View Trial →
NCT04356287 Phase 1, Phase 2
Recruiting
Treatment With Human Umbilical Cord-derived Mesenchymal Stromal Cells in Systemi...
Condition
Sclerosis, Systemic
Start Date
Jan 5, 2023
Location
Canada
Sponsor
Marie Hudson, MD
View Trial →

December 2022 (2 trials)

NCT05917106 N/A
Recruiting
Renal Cancer Monitoring Based on ctDNA Methylomics: A Prospective Cohort Study (...
Condition
Carcinoma
Start Date
Dec 26, 2022
Location
China
Sponsor
Jinling Hospital, China
View Trial →
NCT05319106 N/A
Recruiting
Phase Ⅱ Clinical Study of Human Umbilical Cord Mesenchymal Stem Cells in the Tre...
Condition
Venous Leg Ulcer
Start Date
Dec 15, 2022
Location
China
Sponsor
ShiCang Yu
View Trial →

August 2022 (1 trials)

NCT05671614 N/A
Recruiting
Skeletal Muscle Regeneration in Survivors of Critical Illness: How to Prevent Sa...
Condition
Intensive Care Unit-acquired Weakness
Start Date
Aug 17, 2022
Location
Czechia
Sponsor
Charles University, Czech Repu
View Trial →

June 2022 (1 trials)

NCT05329363 N/A
Recruiting
Evaluation of the Individual Early Psychoeducation Program for Schizophrenic Dis...
Condition
Schizophrenia
Start Date
Jun 17, 2022
Location
France
Sponsor
University Hospital, Tours
View Trial →

May 2022 (1 trials)

NCT05447923 N/A
Recruiting
Addressing Disparities in Colorectal Cancer Screening in Black and Underserved P...
Condition
Colorectal Carcinoma
Start Date
May 22, 2022
Location
United States
Sponsor
Mayo Clinic
View Trial →

January 2022 (1 trials)

NCT05398380 N/A
Recruiting
Liver Transplantation for Non-resectable Colorectal Liver Metastases: Translatio...
Condition
Colorectal Cancer
Start Date
Jan 1, 2022
Location
Spain
Sponsor
Hospital Vall d'Hebron
View Trial →

November 2021 (1 trials)

NCT06085404 N/A
Recruiting
Patients Derived Organoids in Ovarian Cancer
Condition
Ovarian Cancer
Start Date
Nov 25, 2021
Location
Italy
Sponsor
Fondazione Policlinico Univers
View Trial →

February 2021 (1 trials)

NCT04744116 EARLY_Phase 1
Recruiting
Addition of Cord Blood Tissue-Derived Mesenchymal Stromal Cells to Ruxolitinib f...
Condition
Hematopoietic and Lymphoid Cell Neoplasm
Start Date
Feb 17, 2021
Location
United States
Sponsor
M.D. Anderson Cancer Center
View Trial →

January 2021 (2 trials)

NCT04628416 N/A
Recruiting
Evaluation of the PICO® Negative Pressure Dressing System on the Fibula Free Fla...
Condition
Carcinomatous Resections
Start Date
Jan 18, 2021
Location
France
Sponsor
University Hospital, Montpelli
View Trial →
NCT06311006 N/A
Recruiting
Safety Registry of a Fecal Microbiota Transplant Cohort
Condition
Clostridium Difficile Infections
Start Date
Jan 4, 2021
Location
France
Sponsor
Assistance Publique - Hôpitaux
View Trial →

January 2020 (1 trials)

NCT04120714 N/A
Recruiting
Efficacy of Transcranial Direct Current Stimulation (tDCS) in Patients Suffering...
Condition
Pathological Use of Internet Games
Start Date
Jan 6, 2020
Location
France
Sponsor
Centre Hospitalier Universitai
View Trial →
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology